Published in
Radiological Society of North America, Radiology, 2(263), p. 451-460
Links
- ORCID
- Radiological Society of North America
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
Tools
Demyelinating Diseases: Myeloperoxidase as an Imaging Biomarker and Therapeutic Target
Journal article published in 2012 by
Reza Forghani,
Gregory R. Wojtkiewicz,
Yinian Zhang,
Daniel Seeburg,
Benjamin R. M. Bautz,
Benjamin Pulli,
Andrew R. Milewski,
Wendy L. Atkinson,
Yoshiko Iwamoto,
Elizabeth R. Zhang,
Martin Etzrodt,
Elisenda Rodriguez,
Clinton S. Robbins,
Filip K. Swirski,
Ralph Weissleder 
and other authors.
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Data provided by 
Abstract
Myeloperoxidase (MPO) represents a promising therapeutic target, as well as imaging biomarker, for demyelinating diseases and potentially for other diseases in which MPO is implicated.